Vitro Biopharma, Inc. (VTRO)

Vitro Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Year Ending	TTM	Oct 31, 2021	Oct 31, 2020
Net Income	-4.2	-4.76	-1.64
Depreciation & Amortization	0.21	0.16	0.15
Share-Based Compensation	-	2.04	0.27
Other Operating Activities	2.46	1.32	0.36
Operating Cash Flow	-1.53	-1	-0.78
Capital Expenditures	-0.21	-0.03	-0.03
Acquisitions	-	0.37	-
Investing Cash Flow	0.15	0.34	-0.03
Share Issuance / Repurchase	-	1.79	1.03
Debt Issued / Paid	-	2.95	-0.04
Financing Cash Flow	3.56	4.74	0.98
Net Cash Flow	2.18	4.08	0.18
Free Cash Flow	-1.75	-1.03	-0.81
Free Cash Flow Margin	-56.97%	-78.66%	-124.13%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).